Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Needle therapy showdown: which dose best eases stubborn neck pain?

NCT ID NCT07462988

First seen Mar 13, 2026 · Last updated Jun 22, 2026 · Updated 14 times

Summary

This study tested different doses of mesotherapy—injections of lidocaine and meloxicam—against plain saline and dry needling in 80 adults with chronic neck pain. Participants received weekly sessions for three weeks. The goal was to see which approach most reduces pain and improves daily activities, measured at one and three months after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NECK PAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Goztepe Prof. Dr. Suleyman Yalçın City Hospital, Istanbul Medeniyet University

    Istanbul, Kadıköy, 34722, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lidocaine and meloxicam injections

What this could lead to

If successful, this could identify the most effective mesotherapy dose for reducing chronic neck pain and improving daily function.

What could go wrong

This is a small, completed trial with 80 participants. Results may not apply to all neck pain types, and benefits over placebo or dry needling are uncertain.

Conditions

The condition(s) this trial relates to.

Neck Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.